Pacific Biosciences of California Inc PACB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.51
- Day Range
- $2.44–2.65
- 52-Week Range
- $1.07–2.73
- Bid/Ask
- $2.51 / $2.54
- Shares Outstanding
- 310.83M
- Market Cap
- $789.51M
- Volume/Avg
- 26M / 9M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.80
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 485
- Website
- https://www.pacb.com
Valuation
|
Metric
|
PACB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 4.80 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PACB
|
|---|---|
Quick Ratio | 3.89 |
Current Ratio | 4.92 |
Interest Coverage | −16.81 |
Quick Ratio
PACB
Profitability
|
Metric
|
PACB
|
|---|---|
Return on Assets (Normalized) | −19.30% |
Return on Equity (Normalized) | −1,056.56% |
Return on Invested Capital (Normalized) | −20.45% |
Return on Assets
PACB
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|F@wDXYW | LOCK|zP!#> | $169B | |||
| Medtronic PLC
MDT
| LOCK|M%tM#@g | LOCK|Z<mr& | $110B | |||
| Stryker Corp
SYK
| LOCK|<%KVSrby | LOCK|@@! | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|V!%%^C< | LOCK|&y@G | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|!xZ<lqx& | LOCK|!lZv$ | $49B | |||
| DexCom Inc
DXCM
| LOCK|&$B^k^^M | LOCK|fJ>b | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|T<jjkx | LOCK|mw> | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|LPW | LOCK|Fp | $23B | |||
| Steris PLC
STE
| LOCK|$R@<xBT | LOCK|f^B?L | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|jGNKJwgm | LOCK|Hs | $17B |
United States